STOCK TITAN

Gilead Sciences’ Johanna Mercier sells 28,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Gilead Sciences, Inc. Chief Comm & Corp Aff Officer Johanna Mercier exercised options on November 16, 2026, to acquire 25,000 common shares at $72.34 and sold 28,000 shares in three reported transactions that day. Sale prices ranged from $169.57 to $170.56 for 13,922 shares, $170.58 to $171.53 for 13,178 shares, and $171.65 to $171.69 for 900 shares. The transactions were made under a Rule 10b5-1 trading plan adopted February 20, 2025. Following the option transaction, her reported option position was 44,960 options. The options have a four-year vesting schedule: 25% vest on the grant’s first anniversary, with the balance vesting 6.25% quarterly thereafter until fully vested.

Insider Mercier Johanna
Role Chief Comm & Corp Aff Officer
Sold 28,000 shs ($4.78M)
Approx. gross sale proceeds $4.78M
Approx. exercise cost $1.81M
Share of Position Sold 20.2%
Type Security Shares Price Value
Exercise Non-qualified Stock Option (Right to Buy) F1, F5 25,000 $0.00 $0.00
Exercise Common Stock F1 25,000 $72.34 $1.81M
Sale Common Stock F1, F2 13,922 $169.9711 $2.37M
Sale Common Stock F1, F3 13,178 $171.0937 $2.25M
Sale Common Stock F1, F4 900 $171.6856 $155K
Holdings After Transaction: Non-qualified Stock Option (Right to Buy) — 44,960 options (Direct); Common Stock — 110,684 shares (Direct)
Holdings Before and After: Non-qualified Stock Option (Right to Buy), 69,960 to 44,960 options (Direct); Common Stock, 113,684 to 110,684 shares (Direct)
Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (5)
  1. F1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  2. F2. Sale prices for the transactions reported range from $169.57 to $170.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
  3. F3. Sale prices for the transactions reported range from $170.58 to $171.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
  4. F4. Sale prices for the transactions reported range from $171.65 to $171.69. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
  5. F5. The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Shares sold 28,000 shares Across three reported transactions on November 16, 2026
Sale price range $169.57 to $170.56 Sale of 13,922 shares on November 16, 2026
Sale price range $170.58 to $171.53 Sale of 13,178 shares on November 16, 2026
Sale price range $171.65 to $171.69 Sale of 900 shares on November 16, 2026
Shares acquired through option exercise 25,000 shares November 16, 2026
Option exercise price $72.34 per share Options exercised on November 16, 2026
Options following transaction 44,960 options Reported following the November 16, 2026 option transaction
Non-qualified Stock Option (Right to Buy) financial
"Non-qualified Stock Option (Right to Buy)"
Rule 10b5-1 trading plan regulatory
"made pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
four-year vesting schedule financial
"The options have a four-year vesting schedule"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GILD shares did Johanna Mercier sell?

Johanna Mercier sold 28,000 GILD shares on November 16, 2026, in three reported transactions. Sale prices ranged from $169.57 to $170.56 for 13,922 shares, $170.58 to $171.53 for 13,178 shares, and $171.65 to $171.69 for 900 shares. The transactions were made under a Rule 10b5-1 trading plan adopted February 20, 2025.

How many GILD shares did Johanna Mercier acquire through options?

Johanna Mercier exercised options to acquire 25,000 common shares at $72.34. Following the option transaction, her reported option position was 44,960 options. The options have a four-year vesting schedule: 25% vest on the grant’s first anniversary, with the balance vesting 6.25% quarterly thereafter until fully vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mercier Johanna

(Last)(First)(Middle)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE

(Street)
FOSTER CITY CALIFORNIA 94404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Comm & Corp Aff Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026M(1)25,000A$72.34138,684D
Common Stock11/16/2026S(1)13,922D$169.9711(2)124,762D
Common Stock11/16/2026S(1)13,178D$171.0937(3)111,584D
Common Stock11/16/2026S(1)900D$171.6856(4)110,684D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-qualified Stock Option (Right to Buy)$72.3411/16/2026M(1)25,000 (5)03/10/2030Common Stock25,000$044,960D
Explanation of Responses:
1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
2. Sale prices for the transactions reported range from $169.57 to $170.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
3. Sale prices for the transactions reported range from $170.58 to $171.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
4. Sale prices for the transactions reported range from $171.65 to $171.69. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
5. The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Remarks:
/s/ Amy Kim by Power of Attorney for Johanna Mercier11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading